Maryann Gallagher
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Chronic Lymphocytic Leukemia Research, Cancer Treatment and Pharmacology, Cancer-related Molecular Pathways
Most-Cited Works
- → Clinical Activity and Immune Modulation in Cancer Patients Treated With CP-870,893, a Novel CD40 Agonist Monoclonal Antibody(2007)508 cited
- → Analyses of volatile organic compounds from human skin(2008)439 cited
- → Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma(2014)358 cited
- → CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb+ Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment(2014)343 cited
- → Mechanisms of Hypertension Associated With BAY 43-9006(2006)320 cited
- → Phase I Trial of the Antivascular Agent Combretastatin A4 Phosphate on a 5-Day Schedule to Patients With Cancer: Magnetic Resonance Imaging Evidence for Altered Tumor Blood Flow(2003)293 cited
- → Relation between serum N-terminal pro-brain natriuretic peptide and prognosis in patients with hypertrophic cardiomyopathy(2013)136 cited
- → Phase I Clinical/Pharmacokinetic and Pharmacodynamic Trial of the c-raf-1 Antisense Oligonucleotide ISIS 5132 (CGP 69846A)(1999)130 cited
- → Palbociclib (PD0332991)—a Selective and Potent Cyclin-Dependent Kinase Inhibitor(2015)126 cited
- → Phase I Trial of Combretastatin A-4 Phosphate with Carboplatin(2005)98 cited